Previous close | 0.0610 |
Open | 0.0500 |
Bid | 0.0610 x 2236300 |
Ask | 0.0630 x 971900 |
Day's range | 0.0500 - 0.0630 |
52-week range | 0.0500 - 0.2550 |
Volume | |
Avg. volume | 182,121 |
Market cap | 9.45M |
Beta (5Y monthly) | 0.51 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0400 |
Earnings date | 31 Aug 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Kelyniam Global (OTC: KLYG), a leading maker of custom cranial implants, today announced results for its quarter ended March 31, 2023.
Osteopore International (ASX:OSX) ("Osteopore", "OSX" or the "Company"), a Singapore- and Australia-based med-tech company focusing on facilitating natural tissue regeneration, is primed for the global limelight after quietly developing and commercialising its novel 3D-printed bioresorbable scaffold implants that have the potential to revolutionise the way surgeons help patients to naturally regrow bones and other tissues.